Debiopharm International SA

ACTIVE

Forum 'après-demain', Lausanne, Vaud, Switzerlanddebiopharm.comSubsidiary251–500 employeesEstablished: 1979-01-01

Part of après-demain sa

Clinical Trials

22 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1979

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

67.1%

Phase 2

14.5%

Phase 3

11.8%

Not Applicable

5.3%

Trial Status Distribution

Active, not recruiting

27.6%

Completed

38.2%

Not yet recruiting

1.3%

Recruiting

13.2%

Terminated

17.1%

Withdrawn

2.6%

Clinical Trials

Trials sponsored by this organization (76)

Renal Impairment Pharmacokinetics (PK) Trial of Afabicin

Phase 1

Not yet recruiting

interventional

Sep 202660 participants

A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

Phase 3

Recruiting

interventional

Nov 2025119 participants

A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio 1453P in Healthy Adults

Phase 1

Recruiting

interventional

Jun 202588 participants

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

Phase 1

Recruiting

interventional

May 2025154 participants

A Study to Assess the Efficacy, Safety, and Pharmacokinetics of Debio 4326 in Pediatric Participants With Central Precocious Puberty (LIBELULA™ Clinical Trial)

Phase 3

Active, not recruiting

interventional

Jul 202456 participants

Debio 0123 in combination with carboplatin and etoposide in adult participants with small cell lung cancer that recurred or progressed after platinum-based therapy.

Phase 1

Recruiting

interventional

Jun 202478 participants

A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer

Phase 2

Completed

interventional

May 202455 participants

A phase 1 study of oral Debio 0123 in combination with carboplatin in patients with advanced solid tumors

Phase 1

Recruiting

interventional

Apr 2024115 participants

Page 1 of 10

Approvals

No approval data available

News

No news articles found

Back to Organizations